Perspectives of Oncology Practitioners on Hormonal Treatment Following Chemoradiation for Cervical Cancer - Top-Institutions - MDSpire

Perspectives of Oncology Practitioners on Hormonal Treatment Following Chemoradiation for Cervical Cancer

  • By

  • Morgan S. Levy

  • Marilyn Huang

  • Charles S. Dietrich

  • Denise Fabian

  • April 14, 2026

  • 0 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Gynecologic Oncology
    • Radiation Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Gynecologic Oncology
    • Radiation Oncology

  • #3

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Gynecologic Oncology
    • Radiation Oncology

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Gynecologic Oncology
    • Radiation Oncology

  • #5

    University of California, Los Angeles (UCLA) Medical Center
    University of California, Los Angeles (UCLA) Medical Center

    Los Angeles, CA

    Key Differentiators

    • Gynecologic Oncology
    • Radiation Oncology

Original Source(s)

Perspectives of Oncology Practitioners on Hormonal Treatment Following Chemoradiation for Cervical Cancer

  • by Morgan S. Levy, Marilyn Huang, Charles S. Dietrich, Denise Fabian

  • April 14, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

Prescribing Outside the Exam Room

A DEA case exposes how controlled substances can move outside clinical oversight.